The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
8.37
+0.10 (1.21%)
Dec 3, 2025, 3:40 PM EST - Market open
The Joint Revenue
The Joint had revenue of $13.38M in the quarter ending September 30, 2025, with 5.74% growth. This brings the company's revenue in the last twelve months to $54.18M. In the year 2024, The Joint had annual revenue of $51.90M with 10.47% growth.
Revenue (ttm)
$54.18M
Revenue Growth
+10.47%
P/S Ratio
2.32
Revenue / Employee
$73,609
Employees
736
Market Cap
124.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.90M | 4.92M | 10.47% |
| Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
| Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
| Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
| Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
JYNT News
- 16 days ago - Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals" - PRNewsWire
- 26 days ago - The Joint Corp. (JYNT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List - PRNewsWire
- 2 months ago - The Joint Chiropractic Debuts in Delaware - PRNewsWire
- 2 months ago - The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer - GlobeNewsWire
- 4 months ago - The Joint Corp. (JYNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges - GlobeNewsWire
- 4 months ago - The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results - GlobeNewsWire